Evidence map›Paper›PMID 40092638›Full record

ArticleMolecular therapy. Methods & clinical development2025

Cathepsin B inhibition blocks amyloidogenesis in the mouse models of neurological lysosomal diseases MPS IIIC and sialidosis.

Gustavo M Viana, Xuefang Pan, Shuxian Fan, TianMeng Xu, Alexandra Wyatt, Alexey V Pshezhetsky

Abstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gustavo M VianaDivision of Medical Genetics, Centre Hospitalier Universitaire (CHU) Ste-Justine Research Centre, Montreal, QC H3A 0C7, Canada.
Xuefang PanDivision of Medical Genetics, Centre Hospitalier Universitaire (CHU) Ste-Justine Research Centre, Montreal, QC H3A 0C7, Canada.
Shuxian FanDivision of Medical Genetics, Centre Hospitalier Universitaire (CHU) Ste-Justine Research Centre, Montreal, QC H3A 0C7, Canada.
TianMeng XuDivision of Medical Genetics, Centre Hospitalier Universitaire (CHU) Ste-Justine Research Centre, Montreal, QC H3A 0C7, Canada.
Alexandra WyattDivision of Medical Genetics, Centre Hospitalier Universitaire (CHU) Ste-Justine Research Centre, Montreal, QC H3A 0C7, Canada.
Alexey V PshezhetskyDivision of Medical Genetics, Centre Hospitalier Universitaire (CHU) Ste-Justine Research Centre, Montreal, QC H3A 0C7, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuronal accumulation of amyloid aggregates is a hallmark of brain pathology in neurological lysosomal storage diseases (LSDs), including mucopolysaccharidoses (MPS); however, the molecular mechanism underlying this pathology has not been understood. We demonstrate that elevated lysosomal cathepsin B (CTSB) levels and CTSB leakage to the cytoplasm triggers amyloidogenesis in two neurological LSDs. CTSB levels were elevated 3- to 5-fold in the cortices of mouse models of MPS IIIC (

Indexed as

autophagycathepsin Bheparan sulfatelysosomal storage diseasemucopolysaccharidosisneurodegenerationneuroinflammationsialidosisβ-amyloid

Identifiers

PMID40092638
PMCPMC11910108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.